Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis

Chavoustie, S.E., Carter, B.A., Waldbaum, A.S. et al. (8 more authors) (2020) Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis. European Journal of Obstetrics & Gynecology and Reproductive Biology, 245. pp. 13-18. ISSN 0301-2115

Abstract

Metadata

Authors/Creators:
  • Chavoustie, S.E.
  • Carter, B.A.
  • Waldbaum, A.S.
  • Donders, G.G.G.
  • Peters, K.H.
  • Schwebke, J.R.
  • Paull, J.R.A.
  • Price, C.F.
  • Castellarnau, A.
  • McCloud, P.
  • Kinghorn, G.R. ORCID logo https://orcid.org/0000-0001-6608-5076
Copyright, Publisher and Additional Information: © 2019 Elsevier. This is an author produced version of a paper subsequently published in European Journal of Obstetrics & Gynecology and Reproductive Biology. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Astodrimer gel; Bacterial vaginosis; Biofilm; Dendrimer; SPL7013; Treatment; VivaGel®
Dates:
  • Accepted: 27 November 2019
  • Published (online): 28 November 2019
  • Published: February 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 11 Dec 2019 12:09
Last Modified: 28 Nov 2020 01:51
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.ejogrb.2019.11.032
Related URLs:

Share / Export

Statistics